doi: 10.1111/exd.13887
The Injectable vs Oral Debate (And Why It Finally Matters) Look, injectable BPC-157 works
Various general autoantibodies have also been identified in ME/CFS, such as those against cellular components including anchorage molecules (514), HSP-60 (515), microtubule associated protein 2 (516), cardiolipin in 92-95% of ME/CFS patients in two studies (509, 510) but only 4% in another study (506), and neo-antigens (517)
These results show CHO R C5/Bcl-2 cells to be less sensitive to tamoxifen collateral sensitivity than CHO R C5 cells (IC 50 0.593 0.28 M versus 1.49 0.23 M, respectively), consistent with a protective effect likely due to the overexpression of recombinant huBcl-2
However, no significant differences were observed between the groups in terms of IPSS (p = 0.503), QoL scores (p = 0.339), or PSA levels (p = 0.482)